Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS
ClinicalTrials.gov study NCT04827719. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Creation of a Biocollection of Patients with Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored At the Nantes University Hospital
ClinicalTrials.gov study NCT06681363. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
ClinicalTrials.gov study NCT05477589. IPD Sharing: Not stated. Countries: 10. Publications: 0.
A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML
ClinicalTrials.gov study NCT02403310. IPD Sharing: Not stated. Countries: 1. Publications: 0.
5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS
ClinicalTrials.gov study NCT00339196. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03564288. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
ClinicalTrials.gov study NCT05442216. IPD Sharing: NO. Countries: 1. Publications: 0.
HDM201 Added to CT in R/R or Newly Diagnosed AML
ClinicalTrials.gov study NCT03760445. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients
ClinicalTrials.gov study NCT05805072. IPD Sharing: NO. Countries: 1. Publications: 0.
Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML
ClinicalTrials.gov study NCT07304232. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
ClinicalTrials.gov study NCT04256317. IPD Sharing: NO. Countries: 10. Publications: 0.
Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain
ClinicalTrials.gov study NCT03435341. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High-dose Cytarabine and Survival in AML
ClinicalTrials.gov study NCT01034839. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03125876. IPD Sharing: NO. Countries: 1. Publications: 0.
Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT00106600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Oral Venetoclax Tablets in Combination With Subcutaneously (SC) or Intravenously (IV) Inject
ClinicalTrials.gov study NCT05587049. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Pre-emptive Immunomodulation After Allogeneic Stem Cell Transplantation in AML
ClinicalTrials.gov study NCT02888522. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS
ClinicalTrials.gov study NCT00195000. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Pilot Study of Bone Marrow and Peripheral Blood Samples From AML Patients to Characterize the Biologic Heterogeneity of the Disease Using Single Cell Network Profiling (SCNP)
ClinicalTrials.gov study NCT01203033. IPD Sharing: NO. Countries: 1. Publications: 0.
Haplo-SCT vs ASCT With or Without Decitabine in AML CR1
ClinicalTrials.gov study NCT02059720. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.